Varian Medical Systems (NYSE: VAR) reported earnings on April 24. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 29 (Q2), Varian Medical Systems beat slightly on revenues and beat slightly on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share increased. GAAP earnings per share shrank to zero.

Gross margins expanded, operating margins were steady, net margins shrank.

Revenue details
Varian Medical Systems booked revenue of $768.4 million. The 12 analysts polled by S&P Capital IQ expected to see a top line of $758.0 million on the same basis. GAAP reported sales were 100% lower than the prior-year quarter's $720.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.04. The 15 earnings estimates compiled by S&P Capital IQ forecast $1.02 per share. Non-GAAP EPS of $1.04 for Q2 were 8.3% higher than the prior-year quarter's $0.96 per share. GAAP EPS dropped to zero from the prior-year quarter's $0.94.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 41.6%, 40 basis points better than the prior-year quarter. Operating margin was 20.3%, much about the same as the prior-year quarter. Net margin was 14.7%, 30 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $767.6 million. On the bottom line, the average EPS estimate is $1.05.

Next year's average estimate for revenue is $3.04 billion. The average EPS estimate is $4.12.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 385 members out of 400 rating the stock outperform, and 15 members rating it underperform. Among 114 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 111 give Varian Medical Systems a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Varian Medical Systems is outperform, with an average price target of $76.06.

Is Varian Medical Systems the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.